San Diego Business Journal


Recent and archived news stories on: Biotechnology, Doctors, Drugs, Health Insurance, HMO's/PPO's, Hospitals, Medical Devices, Nursing...

Illumina Acquires Australian Firm Conexio Genomics

Illumina Inc. is acquiring Conexio Genomics, an Australian firm that specializes in tissue typing used to match patients and donors for bone marrow or cord blood transplants.

UC San Diego Health Selects Nashville Firm to Run Oncology Center

UC San Diego Health system has chosen Nashville-based e+CancerCare to operate its Chula Vista radiation oncology facility.

James Owens Named Chief Medical Officer at Acadia Therapeutics

San Diego-based Acadia Pharmaceuticals Inc. has brought on Dr. James Owen to serve as chief medical officer and senior vice president of clinical development.

Sharp Community Medical Group CEO to Leave for LA Position

Another San Diego health executive is being recruited to Los Angeles.

Qualcomm Inc. in Talks With a Big Pharma Company About Possible Joint Venture

Qualcomm Inc. is reportedly in talks with the U.K. pharmaceutical company GlaxoSmithKline PLC about a joint venture.

Tease photo

Patty Maysent Appointed CEO of UC San Diego Health

Patty Maysent has been named CEO of UC San Diego Health, effective immediately. She had held the position on an interim basis since former CEO Paul Viviano left in 2015 to run Children's Hospital Los Angeles.

Tease photo

J. Mark Dressel Named CFO at Kisco Senior Living

Carlsbad-based Kisco Senior Living has appointed J. Mark Dressel chief financial officer of its 21 senior living communities across the country.

ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2016

San Diego medical device maker ResMed Inc. reported net income of $90.5 million for the second quarter of fiscal 2016, down 1 percent from the same quarter the previous year.

Tri-City Agrees To Pay $3.3M To Settle Issue

Tri-City Medical Center, a hospital in Oceanside, has agreed to pay nearly $3.3 million in fines to resolve allegations that it violated the Stark Law and False Claims Act.

JPM: Brains, Bucks and A Whole Lot of Biotech

BIOTECH: Gathering Is Unconventional Business, Cultural Event for Sector

You’ve probably heard of CES, the yearly Consumer Electronics Show where exciting new technology — such as virtual reality headsets and self-driving cars — are announced to industry, investors and media.

AmpliPhi Biosciences Corp. Names Steve Martin CFO

AmpliPhi Biosciences Corp., a biotechnology company focused on the development and commercialization of novel bacteriophage-based antibacterial therapeutics, announced Steve R. Martin will be its new chief financial officer.

Millennium Health Announces Board of Directors

Millennium Health, the drug-testing firm that emerged from bankruptcy last month after a $256 million settlement with federal prosecutors, on Tuesday announced the creation of its new board of directors.

Organovo Holdings CFO Barry Michaels Announces Retirement

Organovo Holdings Inc., a San Diego-based 3D bioprinting firm, announced that Chief Financial Officer Barry Michaels will retire at the end of the fiscal year in March. The company will launch an immediate search for his replacement.

Tri-City Agrees to Pay $3.3M in Fines to Settle Allegations Concerning Medicare Billing Procedures

Tri-City Medical Center, a hospital in Oceanside, has agreed to pay nearly $3.3 million in fines to resolve allegations that it violated the Stark Law and False Claims Act.

Tease photo

Renova Therapeutics Names Richard McCloskey Executive VP of Clinical Development

Renova Therapeutics, a San Diego-based gene therapy company, announced Thursday that it has recruited Dr. Richard 'Mac' McCloskey to be executive vice president of clinical development.